GlassScriptPhysician profile
Megan Galindo
NPI 1811344815
$1,471.86
in general payments reported to CMS, 2019-2025
19 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $261 · 2023: $725 · 2024: $174 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $268.97 | 2023-2025 | Aptima |
| Mayne Pharma Commercial LLC | $264.18 | 2022-2025 | |
| Abbvie INC. | $166.92 | 2022-2023 | |
| Daiichi Sankyo INC. | $157.90 | 2022-2025 | Injectafer |
| Sumitomo Pharma America, INC. | $115.28 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $74.49 | 2022-2023 | Slynd |
| Pfizer INC. | $70.23 | 2022-2025 | |
| Davol INC. | $64.89 | 2023-2025 | Arista Ah Flexitip, Arista |
| Biogen, INC. | $59.57 | 2024-2025 | Zurzuvae |
| Ethicon US, LLC | $43.63 | 2022 | |
| Astellas Pharma US INC | $38.40 | 2022-2023 | Veozah |
| Medtronic, INC. | $27.15 | 2025 | Ligasure |
| Pacira Pharmaceuticals Incorporated | $20.99 | 2024 | Exparel |
| Evofem Biosciences, INC. | $18.36 | 2023 | Phexxi |
| Coopersurgical, INC. | $18.11 | 2024 | Paragard T 380a |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $16.77 | 2023 | |
| Myovant Sciences INC. | $16.62 | 2022 | |
| Minerva Surgical, INC | $15.02 | 2025 | |
| Avion Pharmaceuticals | $14.38 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Galindo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.